« Back to Record
Citation APA

Filipits, M., Dafni, U., Gnant, M., Polydoropoulou, V., Hills, M., Kiermaier, A., de Azambuja, E., Larsimont, D., Rojo, F., Viale, G., Toi, M., Harbeck, N., Prichard, K. K., Gelber, R., Dinh, P., Zardavas, D., Leyland-Jones, B., Piccart-Gebhart, M., & Dowsett, M. (2018). Association of p27 and cyclin D1 expression and benefit from adjuvant trastuzumab treatment in HER2-positive early breast cancer: A TransHERA study. Clinical cancer research, 24(13), 3079-3086. doi:10.1158/1078-0432.CCR-17-3473


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/279373

Filipits, M., Dafni, U., Gnant, M., Polydoropoulou, V., Hills, M., Kiermaier, A., de Azambuja, E., Larsimont, D., Rojo, F., Viale, G., Toi, M., Harbeck, N., Prichard, K. K., Gelber, R., Dinh, P., Zardavas, D., Leyland-Jones, B., Piccart-Gebhart, M., & Dowsett, M. (2018). Association of p27 and cyclin D1 expression and benefit from adjuvant trastuzumab treatment in HER2-positive early breast cancer: A TransHERA study. Clinical cancer research, 24(13), 3079-3086. doi:10.1158/1078-0432.CCR-17-3473